💊 ยา A-Z 🧬 เป้าหมาย 🛠 เครื่องมือ 📚 คู่มือ
ยาทั้งหมด หมวดหมู่ยา ด้านการรักษา ผลข้างเคียง
คู่มือ อภิธานศัพท์ ไทม์ไลน์
การเปรียบเทียบ เส้นทางของยา กลุ่มยา
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Varicella Zoster Virus, Live Attenuated

CHEMBL6068357 Phase 4 ได้รับการอนุมัติ Vaccine component
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Live attenuated varicella-zoster virus (VZV), derived from the Oka strain, is the active component of varicella (chickenpox) vaccines and the older live zoster vaccine (Zostavax), inducing long-lasting VZV-specific cellular and humoral immunity. The attenuated virus replicates to a limited extent in vaccinated individuals, producing immunity without causing typical chickenpox disease. It is used for primary prevention of varicella in children and for shingles prevention in older adults, though immunocompromised patients require caution.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Live attenuated varicella-zoster virus (VZV), derived from the Oka strain, is the active component of varicella (chickenpox) vaccines and the older live zoster vaccine (Zostavax), inducing long-lasting VZV-specific cellular and humoral immunity. The attenuated virus replicates to a limited extent in vaccinated individuals, producing immunity without causing typical chickenpox disease. It is used for primary prevention of varicella in children and for shingles prevention in older adults, though immunocompromised patients require caution.

Yes, Varicella Zoster Virus, Live Attenuated is an approved drug. It has reached clinical phase 4. It is classified as a Vaccine component.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068357. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.